Immix Biopharma IMMX SEC Filings

NASDAQ IMMX
$8.28 -0.23 (-2.70%)
As of: Oct 22, 2026 · 3:38 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Immix Biopharma, Inc. (IMMX) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001493152-26-045143Sep 30, 2026 5:10 PM
2FWPOthers0001493152-26-044774Sep 29, 2026 7:25 AM
3424B5Prospectus0001493152-26-044771Sep 29, 2026 7:22 AM
48-KCurrent Report0001493152-26-044761Sep 29, 2026 7:00 AM
510-QQuarterly & Annual Report0001493152-26-036643Aug 7, 2026 9:05 PM
68-KCurrent Report0001493152-26-033829Jul 20, 2026 10:05 AM
7SCHEDULE 13GBeneficial Ownership Report0001274173-26-000156Jun 5, 2026 4:56 PM
88-KCurrent Report0001493152-26-026431May 29, 2026 9:10 PM
94Insider Transaction0001493152-26-026429May 29, 2026 9:05 PM
104Insider Transaction0001493152-26-026430May 29, 2026 9:05 PM
114Insider Transaction0001493152-26-026427May 29, 2026 9:05 PM
124Insider Transaction0001493152-26-026428May 29, 2026 9:05 PM
134Insider Transaction0001493152-26-026426May 29, 2026 9:05 PM
144Insider Transaction0001493152-26-026425May 29, 2026 9:05 PM
154Insider Transaction0001493152-26-026424May 29, 2026 9:05 PM
164Insider Transaction0001493152-26-026422May 29, 2026 9:05 PM
174Insider Transaction0001493152-26-026423May 29, 2026 9:05 PM
188-KCurrent Report0001493152-26-024872May 21, 2026 9:28 PM
19424B5Prospectus0001493152-26-024869May 21, 2026 9:24 PM
20FWPOthers0001493152-26-024715May 21, 2026 10:38 AM
218-KCurrent Report0001493152-26-024707May 21, 2026 10:04 AM
22SCHEDULE 13GBeneficial Ownership Report0001274173-26-000146May 15, 2026 4:38 PM
2310-QQuarterly & Annual Report0001493152-26-021764May 7, 2026 9:17 PM
2410-QQuarterly & Annual Report0001493152-26-021764May 7, 2026 9:17 PM
2510-QQuarterly & Annual Report0001493152-26-021764May 7, 2026 9:17 PM
26SCHEDULE 13GBeneficial Ownership Report0001104659-26-054945May 4, 2026 8:30 PM
27ARSOthers0001493152-26-015324Apr 6, 2026 8:41 PM
28DEFA14AOthers0001493152-26-015322Apr 6, 2026 8:39 PM
29DEF 14AOthers0001493152-26-015320Apr 6, 2026 8:37 PM
308-KCurrent Report0001493152-26-013663Mar 30, 2026 9:39 PM
3110-KQuarterly & Annual Report0001493152-26-013298Mar 27, 2026 9:28 PM
32S-8Prospectus0001493152-26-012722Mar 25, 2026 9:27 PM
338-KCurrent Report0001493152-26-012721Mar 25, 2026 9:23 PM
34424B5Prospectus0001493152-26-012718Mar 25, 2026 9:21 PM
3510-KQuarterly & Annual Report0001493152-26-012714Mar 25, 2026 9:19 PM
36SCHEDULE 13GBeneficial Ownership Report0001104659-26-032741Mar 20, 2026 8:25 PM
37SCHEDULE 13GBeneficial Ownership Report0001104659-26-016248Feb 17, 2026 7:50 PM
38SCHEDULE 13GBeneficial Ownership Report0001104659-26-016248Feb 17, 2026 7:50 PM
39SCHEDULE 13GBeneficial Ownership Report0001104659-26-016248Feb 17, 2026 7:50 PM
40SCHEDULE 13GBeneficial Ownership Report0001274173-26-000078Feb 17, 2026 5:57 PM
41EFFECTOthers9999999995-26-000261Jan 22, 2026 5:15 AM
42CORRESPOthers0001493152-26-002680Jan 16, 2026 12:31 AM
43UPLOADOthers0000000000-26-000603Jan 16, 2026 1:36 PM
44S-3Prospectus0001493152-26-001159Jan 9, 2026 10:28 PM
454Insider Transaction0001493152-25-027329Dec 11, 2025 1:00 AM
464Insider Transaction0001493152-25-027109Dec 10, 2025 11:49 PM
474Insider Transaction0001493152-25-027109Dec 10, 2025 11:49 PM
484Insider Transaction0001493152-25-027109Dec 10, 2025 11:49 PM
494Insider Transaction0001493152-25-027107Dec 10, 2025 11:47 PM
504Insider Transaction0001493152-25-027107Dec 10, 2025 11:47 PM
...

Immix Biopharma, Inc. SEC Filings API

Pull Immix Biopharma, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=IMMX&formtype=10-K,10-Q&api_key=YOUR_API_KEY